Oculis Holding AG (OCS) stock
OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
$7.64+0.14 (+1.87%)
Close on Nov 13, 2026Market cap $459.08MP/E –Yield –
Oculis total assets
Total assets on the balance sheet at the end of each period.
Oculis's total assets was CHF 250.34M at Jun 30, 2026. For fiscal 2025 it was CHF 235.96M, up 96.1% from the year before. The highest annual figure on record is CHF 235.96M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | CHF 235.96M | +96.1% |
| FY2024 | Dec 31, 2024 | CHF 120.35M | +5.2% |
| FY2023 | Dec 31, 2023 | CHF 114.35M | +208.6% |
| FY2022 | Dec 31, 2022 | CHF 37.06M | -36.2% |
| FY2021 | Dec 31, 2021 | CHF 58.04M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | CHF 250.34M | +80.4% |
| Q4 FY2025 | Dec 31, 2025 | CHF 235.96M | +106.3% |
| Q2 FY2025 | Jun 30, 2025 | CHF 181.62M | +390.1% |
| Q4 FY2024 | Dec 31, 2024 | CHF 120.35M | +107.4% |
| Q2 FY2024 | Jun 30, 2024 | CHF 138.73M | – |
| Q4 FY2023 | Dec 31, 2023 | CHF 114.35M | – |
| Q4 FY2022 | Dec 31, 2022 | CHF 37.06M | – |
| Q4 FY2021 | Dec 31, 2021 | CHF 58.04M | – |
See a number that looks wrong?